The Lancet Oncology in conversation with

David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer

June 30, 2022 The Lancet Oncology
The Lancet Oncology in conversation with
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer
Show Notes

David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.

Read the full article:
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv